These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25908996)

  • 1. Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy.
    Iyer AS; Leggat DJ; Ohtola JA; Duggan JM; Georgescu CA; Al Rizaiza AA; Khuder SA; Khaskhely NM; Westerink J
    J AIDS Clin Res; 2015 Feb; 6(2):. PubMed ID: 25908996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals.
    Leggat DJ; Iyer AS; Ohtola JA; Kommoori S; Duggan JM; Georgescu CA; Khuder SA; Khaskhely NM; Westerink MJ
    J AIDS Clin Res; 2015 Feb; 6(2):. PubMed ID: 25908995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
    Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
    HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy.
    Subramaniam KS; Segal R; Lyles RH; Rodriguez-Barradas MC; Pirofski LA
    J Infect Dis; 2003 Mar; 187(5):758-68. PubMed ID: 12599049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
    Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
    Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients.
    Tsachouridou O; Skoura L; Zebekakis P; Margariti A; Georgiou A; Daniilidis M; Malisiovas N; Metallidis S
    Int J Infect Dis; 2015 Sep; 38():24-31. PubMed ID: 26192868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells.
    Leggat DJ; Thompson RS; Khaskhely NM; Iyer AS; Westerink MA
    J Infect Dis; 2013 Jul; 208(1):101-8. PubMed ID: 23547142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and Functional Antibody Responses to the 13-Valent Conjugate and/or 23-Valent Purified Polysaccharide Vaccine in Aging HIV-Infected Adults.
    Ohtola JA; Saul-McBeth JL; Iyer AS; Leggat DJ; Khuder SA; Khaskhely NM; Westerink MJ
    J AIDS Clin Res; 2016 Mar; 7(3):. PubMed ID: 27158552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease.
    Gaultier GN; McCready W; Ulanova M
    BMC Immunol; 2019 Nov; 20(1):41. PubMed ID: 31718534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults.
    Iyer AS; Khaskhely NM; Leggat DJ; Ohtola JA; Saul-McBeth JL; Khuder SA; Westerink MA
    PLoS One; 2016; 11(3):e0150261. PubMed ID: 26930208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic analysis of pneumococcal polysaccharide-specific B cells.
    Khaskhely N; Mosakowski J; Thompson RS; Khuder S; Smithson SL; Westerink MA
    J Immunol; 2012 Mar; 188(5):2455-63. PubMed ID: 22271652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.
    Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
    Vaccine; 1999 Oct; 18(5-6):524-30. PubMed ID: 10519943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy.
    Lu CL; Chang SY; Chuang YC; Liu WC; Su CT; Su YC; Chang SF; Hung CC
    Vaccine; 2014 Feb; 32(9):1031-5. PubMed ID: 24440112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
    Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.
    Ho YL; Brandão AP; de Cunto Brandileone MC; Lopes MH
    Vaccine; 2013 Aug; 31(37):4047-53. PubMed ID: 23684823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.
    Kolibab K; Smithson SL; Shriner AK; Khuder S; Romero-Steiner S; Carlone GM; Westerink MA
    Immun Ageing; 2005 Jun; 2():10. PubMed ID: 15982420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy.
    Tangsinmankong N; Kamchaisatian W; Day NK; Sleasman JW; Emmanuel PJ
    Ann Allergy Asthma Immunol; 2004 May; 92(5):558-64. PubMed ID: 15191025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users.
    Amendola A; Tanzi E; Zappa A; Colzani D; Boschini A; Musher DM; Zanetti AR
    Vaccine; 2002 Nov; 20(31-32):3720-4. PubMed ID: 12399200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.